LT-001 (lncTAC)

N/A

Report date: 2022/12/27 11:47:49
NMEFirst In Class

Base Information

Drug NameLT-001 (lncTAC)
Drug Alias NameLT-001 (lncRNA or long non-coding RNA)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompanieslncTAC
China Registration ClassN/A

Develop Information

Active CompanieslncTAC
Inactive CompaniesN/A
Active IndicationsAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A